CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study (Q52004908)

19 April 2018

reason for preferred rank

title

CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study (English)

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(03)01836-X

24 March 2024

CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576659

24 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(03)01836-X

24 March 2024

6

Hans D Ochs

1 reference

19 April 2018

Thomas Casale

2

object named as

Thomas B. Casale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576659

24 March 2024

author name string

Ellen Frankel

3

1 reference

19 April 2018

Bernard Goffe

4

1 reference

19 April 2018

Nicholas Lowe

5

1 reference

19 April 2018

Ken Washenik

8

1 reference

19 April 2018

Alice B. Gottlieb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576659

24 March 2024

Janet L. Roberts

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576659

24 March 2024

Akshay K. Vaishnaw

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576659

24 March 2024

Kenneth B. Gordon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576659

24 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

19 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S019096220301836X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(03)01836-X

https://api.elsevier.com/content/article/PII:S019096220301836X?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(03)01836-X

Journal of the American Academy of Dermatology

24 March 2024

published in

1 reference

19 April 2018

volume

49

1 reference

19 April 2018

issue

5

1 reference

19 April 2018

page(s)

816-825

1 reference

19 April 2018

Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

The immune system. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

1 reference

7 January 2021

Human antibody responses to bacteriophage phi X 174: sequential induction of IgM and IgG subclass antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Immune response after splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Regulation of antibody responses: the role of complement and adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Visualizing the generation of memory CD4 T cells in the whole body

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

In vivo estimates of division and death rates of human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Lifespan of human lymphocyte subsets defined by CD45 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Booster effect of low doses of tetanus toxoid in elderly vaccinees

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901836-X

7 January 2021

Antibody Response to Successive Booster Doses of Tetanus Toxoid in Adults

37

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(03)01836-X

24 March 2024

Identifiers

1 reference

19 April 2018

1 reference

19 April 2018